Cencora Stock Price To Sales

COR Stock

USD 245.02 0.67 0.27%

Cencora fundamentals help investors to digest information that contributes to Cencora's financial success or failures. It also enables traders to predict the movement of Cencora Stock. The fundamental analysis module provides a way to measure Cencora's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cencora stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	0.15	0.14

As of 11/22/2024, Price To Sales Ratio is likely to drop to 0.14.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cencora Company Price To Sales Analysis

Cencora's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Cencora Price To Sales

0.16 X

Most of Cencora's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cencora is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Cencora Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Cencora is extremely important. It helps to project a fair market value of Cencora Stock properly, considering its historical fundamentals such as Price To Sales. Since Cencora's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cencora's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cencora's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Current Deferred Revenue	Good Will	Short Term Investments	Net Tangible Assets	Long Term Debt	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment	Long Term Debt Total	Capital Surpluse	Cash And Equivalents
Total Assets		-0.29	0.48	0.77	1.0	0.99	1.0	1.0	0.71	0.7	0.8	-0.14	0.98	0.0	-0.85	0.54	-0.73	0.74	0.68	-0.78	0.71	0.41	0.78	-0.84
Total Stockholder Equity	-0.29		-0.09	0.26	-0.29	-0.33	-0.34	-0.3	-0.46	-0.2	-0.29	-0.15	-0.3	0.17	0.61	-0.28	0.59	-0.6	-0.25	0.32	-0.53	-0.37	-0.35	0.42
Net Debt	0.48	-0.09		0.29	0.43	0.43	0.48	0.43	0.29	0.06	0.25	0.5	0.49	0.16	-0.52	0.73	0.09	0.23	0.06	-0.34	0.64	0.8	0.28	-0.54
Retained Earnings	0.77	0.26	0.29		0.79	0.77	0.74	0.76	0.44	0.73	0.75	-0.44	0.78	-0.11	-0.45	0.24	-0.44	0.46	0.65	-0.73	0.32	-0.01	0.68	-0.6
Accounts Payable	1.0	-0.29	0.43	0.79		1.0	0.99	1.0	0.71	0.74	0.83	-0.21	0.98	-0.04	-0.83	0.5	-0.76	0.74	0.72	-0.8	0.68	0.34	0.8	-0.83
Net Receivables	0.99	-0.33	0.43	0.77	1.0		0.99	0.99	0.7	0.75	0.84	-0.17	0.98	-0.05	-0.87	0.54	-0.77	0.77	0.73	-0.82	0.72	0.38	0.83	-0.87
Total Liab	1.0	-0.34	0.48	0.74	0.99	0.99		1.0	0.72	0.7	0.8	-0.13	0.98	-0.01	-0.87	0.55	-0.75	0.76	0.68	-0.79	0.73	0.42	0.79	-0.85
Total Current Assets	1.0	-0.3	0.43	0.76	1.0	0.99	1.0		0.71	0.7	0.79	-0.17	0.97	-0.01	-0.84	0.52	-0.76	0.75	0.69	-0.77	0.7	0.38	0.79	-0.83
Short Term Debt	0.71	-0.46	0.29	0.44	0.71	0.7	0.72	0.71		0.44	0.52	-0.35	0.67	-0.4	-0.73	0.25	-0.67	0.89	0.45	-0.65	0.64	0.26	0.61	-0.59
Common Stock	0.7	-0.2	0.06	0.73	0.74	0.75	0.7	0.7	0.44		0.97	-0.43	0.74	-0.44	-0.62	0.27	-0.74	0.55	0.86	-0.9	0.34	-0.04	0.85	-0.78
Intangible Assets	0.8	-0.29	0.25	0.75	0.83	0.84	0.8	0.79	0.52	0.97		-0.31	0.85	-0.36	-0.73	0.42	-0.74	0.62	0.87	-0.93	0.5	0.13	0.9	-0.87
Current Deferred Revenue	-0.14	-0.15	0.5	-0.44	-0.21	-0.17	-0.13	-0.17	-0.35	-0.43	-0.31		-0.11	0.53	-0.08	0.59	0.39	-0.36	-0.33	0.35	0.29	0.73	-0.27	-0.03
Good Will	0.98	-0.3	0.49	0.78	0.98	0.98	0.98	0.97	0.67	0.74	0.85	-0.11		0.01	-0.84	0.56	-0.73	0.71	0.73	-0.8	0.71	0.39	0.81	-0.86
Short Term Investments	0.0	0.17	0.16	-0.11	-0.04	-0.05	-0.01	-0.01	-0.4	-0.44	-0.36	0.53	0.01		0.16	0.06	0.2	-0.34	-0.36	0.49	-0.08	0.21	-0.4	0.27
Net Tangible Assets	-0.85	0.61	-0.52	-0.45	-0.83	-0.87	-0.87	-0.84	-0.73	-0.62	-0.73	-0.08	-0.84	0.16		-0.69	0.73	-0.83	-0.59	0.81	-0.89	-0.66	-0.77	0.93
Long Term Debt	0.54	-0.28	0.73	0.24	0.5	0.54	0.55	0.52	0.25	0.27	0.42	0.59	0.56	0.06	-0.69		-0.13	0.3	0.39	-0.43	0.86	0.87	0.52	-0.74
Net Invested Capital	-0.73	0.59	0.09	-0.44	-0.76	-0.77	-0.75	-0.76	-0.67	-0.74	-0.74	0.39	-0.73	0.2	0.73	-0.13		-0.79	-0.7	0.7	-0.43	-0.02	-0.72	0.65
Short Long Term Debt	0.74	-0.6	0.23	0.46	0.74	0.77	0.76	0.75	0.89	0.55	0.62	-0.36	0.71	-0.34	-0.83	0.3	-0.79		0.59	-0.76	0.72	0.29	0.76	-0.71
Capital Stock	0.68	-0.25	0.06	0.65	0.72	0.73	0.68	0.69	0.45	0.86	0.87	-0.33	0.73	-0.36	-0.59	0.39	-0.7	0.59		-0.77	0.47	0.03	0.95	-0.76
Net Working Capital	-0.78	0.32	-0.34	-0.73	-0.8	-0.82	-0.79	-0.77	-0.65	-0.9	-0.93	0.35	-0.8	0.49	0.81	-0.43	0.7	-0.76	-0.77		-0.6	-0.24	-0.9	0.91
Property Plant Equipment	0.71	-0.53	0.64	0.32	0.68	0.72	0.73	0.7	0.64	0.34	0.5	0.29	0.71	-0.08	-0.89	0.86	-0.43	0.72	0.47	-0.6		0.81	0.65	-0.81
Long Term Debt Total	0.41	-0.37	0.8	-0.01	0.34	0.38	0.42	0.38	0.26	-0.04	0.13	0.73	0.39	0.21	-0.66	0.87	-0.02	0.29	0.03	-0.24	0.81		0.24	-0.57
Capital Surpluse	0.78	-0.35	0.28	0.68	0.8	0.83	0.79	0.79	0.61	0.85	0.9	-0.27	0.81	-0.4	-0.77	0.52	-0.72	0.76	0.95	-0.9	0.65	0.24		-0.89
Cash And Equivalents	-0.84	0.42	-0.54	-0.6	-0.83	-0.87	-0.85	-0.83	-0.59	-0.78	-0.87	-0.03	-0.86	0.27	0.93	-0.74	0.65	-0.71	-0.76	0.91	-0.81	-0.57	-0.89

Click cells to compare fundamentals

Cencora Price To Sales Historical Pattern

Today, most investors in Cencora Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cencora's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cencora price to sales as a starting point in their analysis.

Cencora Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Cencora

Price To Sales Ratio Over Time

Cencora Price To Sales Ratio

Price To Sales Ratio

0.14

At this time, Cencora's Price To Sales Ratio is relatively stable compared to the past year.

Based on the latest financial disclosure, Cencora has a Price To Sales of 0.1638 times. This is 98.29% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 98.57% higher than that of the company.

Cencora Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cencora's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cencora could also be used in its relative valuation, which is a method of valuing Cencora by comparing valuation metrics of similar companies.

Cencora is currently under evaluation in price to sales category among its peers.

Cencora ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cencora's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cencora's managers, analysts, and investors.

Environmental

Governance

Social

Cencora Fundamentals

	Return On Equity	2.09
	Return On Asset	0.031
	Profit Margin	0.01 %
	Operating Margin	0.01 %
	Current Valuation	49.41 B
	Shares Outstanding	196.01 M
	Shares Owned By Insiders	10.47 %
	Shares Owned By Institutions	91.77 %
	Number Of Shares Shorted	9.96 M
	Price To Earning	82.16 X
	Price To Book	61.21 X
	Price To Sales	0.16 X
	Revenue	293.96 B
	Gross Profit	8.33 B
	EBITDA	3.25 B
	Net Income	1.51 B
	Cash And Equivalents	2.59 B
	Cash Per Share	0.08 X
	Total Debt	4.39 B
	Current Ratio	0.58 X
	Book Value Per Share	4.01 X
	Cash Flow From Operations	3.48 B
	Short Ratio	7.44 X
	Earnings Per Share	7.52 X
	Price To Earnings To Growth	1.27 X
	Target Price	267.32
	Number Of Employees	46 K
	Beta	0.44
	Market Capitalization	48.16 B
	Total Asset	67.1 B
	Retained Earnings	4.32 B
	Working Capital	(6.03 B)
	Current Asset	19.09 M
	Current Liabilities	111.82 M
	Annual Yield	0.01 %
	Five Year Return	3.65 %
	Net Asset	67.1 B
	Last Dividend Paid	2.04

About Cencora Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cencora's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cencora using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cencora based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Cencora

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cencora position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cencora will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cencora Stock

0.72	GH	Guardant Health	Pair Corr
0.78	LH	Laboratory	Pair Corr

Moving against Cencora Stock

0.67	DRIO	DarioHealth Corp	Pair Corr
0.46	EKSO	Ekso Bionics Holdings	Pair Corr
0.38	VERO	Venus Concept	Pair Corr

The ability to find closely correlated positions to Cencora could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cencora when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cencora - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cencora to buy it.

The correlation of Cencora is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cencora moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cencora moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cencora can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Cencora Stock Analysis

When running Cencora's price analysis, check to measure Cencora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cencora is operating at the current time. Most of Cencora's value examination focuses on studying past and present price action to predict the probability of Cencora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cencora's price. Additionally, you may evaluate how the addition of Cencora to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC